Intuitive Surgical, Inc. $ISRG Position Increased by TABR Capital Management LLC

TABR Capital Management LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 482 shares of the medical equipment provider’s stock after purchasing an additional 60 shares during the quarter. Intuitive Surgical makes up approximately 0.2% of TABR Capital Management LLC’s holdings, making the stock its 28th largest position. TABR Capital Management LLC’s holdings in Intuitive Surgical were worth $262,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in ISRG. Chilton Capital Management LLC grew its position in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new position in Intuitive Surgical during the 1st quarter valued at about $26,000. LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical during the 1st quarter valued at about $30,000. TD Capital Management LLC grew its position in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ISRG has been the subject of several analyst reports. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Evercore ISI raised their price target on Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a report on Tuesday, July 8th. Finally, Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Intuitive Surgical Stock Performance

ISRG opened at $447.23 on Wednesday. The company has a market capitalization of $160.32 billion, a PE ratio of 62.38, a P/E/G ratio of 4.60 and a beta of 1.61. The stock’s fifty day moving average is $466.61 and its 200-day moving average is $500.97. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period in the previous year, the company earned $1.78 earnings per share. Intuitive Surgical’s revenue was up 21.4% compared to the same quarter last year. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 in the last quarter. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.